In the study, a once-daily, single-tablet combination of bictegravir and lenacapavir was as effective as Gilead's existing ...
Howard County will dispense the biannual prevention injection Yeztugo, a less time-consuming option than current preventative ...
This year has been one for the books in medicine. From Ozempic’s expanded role in protecting failing kidneys to long‑acting ...
Clinical Trials Arena on MSN
Gilead’s HIV ART combo deemed non-inferior in second phase III trial
Gilead Sciences’ human immunodeficiency virus (HIV) single-tablet combination antiretroviral therapy (ART) has proven ...
In 2025, drug approvals widen treatment options for chronic diseases, infections and pain, including Ozempic kidney ...
Here’s a closer look at the top pharmaceutical companies that have earned favorable rankings from Wolfe Research analysts. Johnson & Johnson takes the top spot with growth primarily driven by new ...
Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and ...
Finding the best blue-chip stocks to buy is never a simple task, especially when markets are shifting. Economic uncertainty, changing interest-rate expectations and the rapid evolution of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results